Table 1 Studies’ characteristics
Author | Year of publication | Participant comorbidity number DM(intervention, control) HTN(intervention, control) | Sample size number (intervention, control) | Age year (intervention, control) Mean (SD) | Gender (intervention, control) Number of females | Cell origin | Route of delivery | Method of measurement | Follow-up duration (month) |
|---|---|---|---|---|---|---|---|---|---|
Hare | 2009 | 6,1 16,9 | 34,19 | 59(12.3) 55.1(10.2) | 6,4 | BMSC | IV | Echocardiography, MRI | 6 |
Gao | 2013 | 6,5 13,11 | 21,22 | 55(1.6) 58.6(2.5) | 0,3 | BMSC | IC | Echocardiography, SPECT | 24 |
Chen | 2004 | Not reported | 34,35 | 58(7) 57(5) | 2,1 | BMSC | IC | Echocardiography, PET | 3 |
Chulikana | 2014 | Not reported | 10,10 | 47.31(12.1) 47.79(6.48) | 0,2 | BMSC | IC | Echocardiography, MRI, SPECT | 24 |
Penn | 2018 | 1,2 4,3 | 19,6 | 53(9.9) 53(8) | 1,1 | BMSC | IC | Echocardiography, angiography | Â |
Lee | 2014 | 5,8 14,12 | 30,28 | 53.9(10.5) 54.2(7.7) | 3,3 | BMSC | IC | Echocardiography, SPECT | 182.6,179.5 |
Rodrigo | 2013 | 1,5 4,18 | 9,45 | 56(8) 61(11) | 2,10 | BMSC | IM | Echocardiography, SPECT | 54.3 |
Gao | 2015 | 17,14 33,26 | 58,58 | 57.3(103) 56.7(1.7) | 3,7 | Umblical | IC | Echocardiography, SPECT | 18 |
Wang | 2014 | Not reported | 28,30 | 56.1(9.8) 58(10.2) | 16,9 | BMSC | IC | Echocardiography, angiography | 6 |
Kharlamov | 2007 | 45,48,55 131,127,132 | 131,127,132 | 58.32(9.12) 59.44(10.26) 57.25(7.68) | 8,8,15 | autologous, adipose | IM | Echocardiography, angiography, SPECT | 12 |
Hautgraff | 2012 | Not reported 6,2 | 9,4 | 61(2.1) 55(7.5) | 2,0 | Adipose | IC | SPECT | 36 |
Kim | 2018 | 3,2 5,5 | 14,12 14,12 | 56.45 56.45 | 0,0 | BMSC | IC | SPECT Echocardiography | 6 |
Zhang | 2021 | 8,5 13,11 | 21,22 | 58.94 | 1,3 | BMSC | IC | Echocardiography | 12 |